Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Adjunct to Propofol for ECT
NCT02579642Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Oct 2015
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by University of Alberta. Started Oct 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02579642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579642.